Eden Biodesign signs marketing services agreement with Human Genome Sciences

UK-based Eden Biodesign, provider of biopharmaceutical process development and cGMP manufacturing services, has entered into a marketing services agreement with US company Human Genome Sciences (HGS).

Under the terms of the agreement, Eden Biodesign will use its expertise and global presence in the biopharmaceutical contract manufacturing market to assist HGS in identifying new manufacturing clients for its large-scale commercial cell culture production facilities located in Rockville, Maryland.

Both companies will use their combined expertise in process development, process scale-up, technology transfer, analytical and international regulatory support for biopharmaceuticals to provide customers with rapid and cost-effective transition into cGMP manufacturing at scales up to 20,000L and seamless access to commercial production capacity for biopharmaceuticals derived from mammalian cell culture.

"This alliance is particularly significant for Eden Biodesign," said ceo Dr Crawford Brown. "In addition to our process development and clinical scale cGMP production services, our growing portfolio of clients may now also have seamless access to Human Genome Sciences" expertise in late-stage process development and state-of-the-art large-scale production facilities as their products progress towards, and in to, commercial launch."